{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:54:36Z","timestamp":1794362076841,"version":"4.9.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["3APF-2019-744-AN"],"award-info":[{"award-number":["3APF-2019-744-AN"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Metabolic syndrome (MetS) is a complex disorder characterized by abdominal obesity, elevated blood pressure, hyperlipidemia, and elevated fasting blood glucose levels. The diagnostic criteria for MetS in adults are well-established, but there is currently no consensus on the definition in children and adolescents. The etiology of MetS is believed to involve a complex interplay between genetic predisposition and environmental factors. While genetic predisposition explains only a small part of MetS pathogenesis, modifiable environmental risk factors play a significant role. Factors such as maternal weight during pregnancy, children\u2019s lifestyle, sedentariness, high-fat diet, fructose and branched-chain amino acid consumption, vitamin D deficiency, and sleep disturbances contribute to the development of MetS. Early identification and treatment of MetS in children and adolescents is crucial to prevent the development of chronic diseases later in life. In this review we discuss the latest research on factors contributing to the pathogenesis of MetS in children, focusing on non-modifiable and modifiable risk factors, including genetics, dysbiosis and chronic low-grade inflammation.<\/jats:p>","DOI":"10.1007\/s12020-023-03642-x","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T08:04:05Z","timestamp":1703232245000},"page":"16-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Mechanisms and risk factors of metabolic syndrome in children and adolescents"],"prefix":"10.1007","volume":"84","author":[{"given":"Valentina","family":"Codazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Frontino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5639-9415","authenticated-orcid":false,"given":"Alessandra","family":"Petrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,22]]},"reference":[{"issue":"7","key":"3642_CR1","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1515\/jpem-2019-0552","volume":"33","author":"GM Christian Flemming","year":"2020","unstructured":"G.M. Christian Flemming et al. Definition and early diagnosis of metabolic syndrome in children. J. Pediatr. Endocrinol. Metab. 33(7), 821\u2013833 (2020)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"5","key":"3642_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","volume":"8","author":"P Zimmet","year":"2007","unstructured":"P. Zimmet et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr. Diabetes 8(5), 299\u2013306 (2007)","journal-title":"Pediatr. Diabetes"},{"issue":"16","key":"3642_CR3","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1161\/01.CIR.0000145117.40114.C7","volume":"110","author":"SD de Ferranti","year":"2004","unstructured":"S.D. de Ferranti et al. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 110(16), 2494\u20132497 (2004)","journal-title":"Circulation"},{"issue":"8","key":"3642_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/archpedi.157.8.821","volume":"157","author":"S Cook","year":"2003","unstructured":"S. Cook et al. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch. Pediatr. Adolesc. Med. 157(8), 821\u2013827 (2003)","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"1","key":"3642_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/adc.2003.036467","volume":"90","author":"RM Viner","year":"2005","unstructured":"R.M. Viner et al. Prevalence of the insulin resistance syndrome in obesity. Arch. Dis. Child. 90(1), 10\u201314 (2005)","journal-title":"Arch. Dis. Child."},{"issue":"2","key":"3642_CR6","doi-asserted-by":"publisher","first-page":"e20171603","DOI":"10.1542\/peds.2017-1603","volume":"140","author":"SN Magge","year":"2017","unstructured":"S.N. Magge et al. The metabolic syndrome in children and adolescents: shifting the focus to cardiometabolic risk factor clustering. Pediatrics 140(2), e20171603 (2017).","journal-title":"Pediatrics"},{"issue":"2","key":"3642_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1530\/EJE-21-0238","volume":"185","author":"A Tropeano","year":"2021","unstructured":"A. Tropeano et al. The metabolic syndrome in pediatrics: do we have a reliable definition? A systematic review. Eur. J. Endocrinol. 185(2), 265\u2013278 (2021)","journal-title":"Eur. J. Endocrinol."},{"issue":"9579","key":"3642_CR8","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(07)60958-1","volume":"369","author":"P Zimmet","year":"2007","unstructured":"P. Zimmet et al. The metabolic syndrome in children and adolescents. Lancet 369(9579), 2059\u20132061 (2007)","journal-title":"Lancet"},{"issue":"4","key":"3642_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jpeds.2004.06.044","volume":"145","author":"JR Fernandez","year":"2004","unstructured":"J.R. Fernandez et al. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J. Pediatr. 145(4), 439\u2013444 (2004)","journal-title":"J. Pediatr."},{"issue":"8","key":"3642_CR10","doi-asserted-by":"publisher","first-page":"e005632","DOI":"10.1161\/JAHA.117.005632","volume":"6","author":"J Koskinen","year":"2017","unstructured":"J. Koskinen et al. Childhood Age and Associations Between Childhood Metabolic Syndrome and Adult Risk for Metabolic Syndrome, Type 2 Diabetes Mellitus and Carotid Intima Media Thickness: The International Childhood Cardiovascular Cohort Consortium. J. Am. Heart Assoc. 6(8), e005632 (2017).","journal-title":"J. Am. Heart Assoc."},{"issue":"25","key":"3642_CR11","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1056\/NEJMoa1503840","volume":"374","author":"G Twig","year":"2016","unstructured":"G. Twig et al. Body-Mass Index in 2.3 million adolescents and cardiovascular death in adulthood. N. Engl. J. Med. 374(25), 2430\u20132440 (2016)","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"3642_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.amjcard.2005.07.133","volume":"97","author":"C Gazzaruso","year":"2006","unstructured":"C. Gazzaruso et al. Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus. Am. J. Cardiol. 97(2), 236\u2013239 (2006)","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"3642_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S2352-4642(21)00374-6","volume":"6","author":"JJ Noubiap","year":"2022","unstructured":"J.J. Noubiap et al. Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: a systematic review and modelling analysis. Lancet Child Adolesc. Health 6(3), 158\u2013170 (2022)","journal-title":"Lancet Child Adolesc. Health"},{"issue":"1","key":"3642_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41366-020-00713-1","volume":"45","author":"C Reisinger","year":"2021","unstructured":"C. Reisinger et al. The prevalence of pediatric metabolic syndrome-a critical look on the discrepancies between definitions and its clinical importance. Int. J. Obes. 45(1), 12\u201324 (2021)","journal-title":"Int. J. Obes."},{"issue":"1","key":"3642_CR15","first-page":"25","volume":"28","author":"V Higgins","year":"2017","unstructured":"V. Higgins, K. Adeli, Pediatric metabolic syndrome: pathophysiology and laboratory assessment. EJIFCC 28(1), 25\u201342 (2017)","journal-title":"EJIFCC"},{"key":"3642_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-12-800141-7.00004-8","volume":"65","author":"R Kursawe","year":"2014","unstructured":"R. Kursawe, N. Santoro, Metabolic syndrome in pediatrics. Adv. Clin. Chem. 65, 91\u2013142 (2014)","journal-title":"Adv. Clin. Chem."},{"issue":"2","key":"3642_CR17","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","volume":"23","author":"G Fahed","year":"2022","unstructured":"G. Fahed et al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int. J. Mol. Sci. 23(2), 786 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"3642_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1210\/edrv.23.2.0461","volume":"23","author":"GF Lewis","year":"2002","unstructured":"G.F. Lewis et al. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23(2), 201\u2013229 (2002)","journal-title":"Endocr. Rev."},{"issue":"5","key":"3642_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrm2391","volume":"9","author":"A Guilherme","year":"2008","unstructured":"A. Guilherme et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9(5), 367\u2013377 (2008)","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"3642_CR20","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1210\/jc.2004-2305","volume":"90","author":"R Weiss","year":"2005","unstructured":"R. Weiss et al. The \u201cobese insulin-sensitive\u201d adolescent: importance of adiponectin and lipid partitioning. J. Clin. Endocrinol. Metab. 90(6), 3731\u20133737 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3642_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/nu8020054","volume":"8","author":"J Bermudez-Cardona","year":"2016","unstructured":"J. Bermudez-Cardona, C. Velasquez-Rodriguez, Profile of free fatty acids and fractions of phospholipids, cholesterol esters and triglycerides in serum of obese youth with and without metabolic syndrome. Nutrients 8(2), 54 (2016)","journal-title":"Nutrients"},{"issue":"2","key":"3642_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2337\/db07-0932","volume":"57","author":"SE Taksali","year":"2008","unstructured":"S.E. Taksali et al. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes 57(2), 367\u2013371 (2008)","journal-title":"Diabetes"},{"issue":"8","key":"3642_CR23","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2337\/dc10-0284","volume":"33","author":"E D\u2019Adamo","year":"2010","unstructured":"E. D\u2019Adamo et al. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 33(8), 1817\u20131822 (2010)","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"3642_CR24","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1530\/EJE-07-0125","volume":"157","author":"R Weiss","year":"2007","unstructured":"R. Weiss, Fat distribution and storage: how much, where, and how? Eur. J. Endocrinol. 157(Suppl 1), S39\u2013S45 (2007)","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"3642_CR25","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1111\/j.2047-6310.2012.00098.x","volume":"8","author":"OT Hardy","year":"2013","unstructured":"O.T. Hardy et al. Increased Toll-like receptor (TLR) mRNA expression in monocytes is a feature of metabolic syndrome in adolescents. Pediatr. Obes. 8(1), e19\u2013e23 (2013)","journal-title":"Pediatr. Obes."},{"issue":"Suppl 1","key":"3642_CR26","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.2337\/diabetes.50.2007.S118","volume":"50","author":"RH Unger","year":"2001","unstructured":"R.H. Unger, Y.T. Zhou, Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 50(Suppl 1), S118\u2013S121 (2001)","journal-title":"Diabetes"},{"issue":"6","key":"3642_CR27","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1002\/hep.22858","volume":"49","author":"AM Cali","year":"2009","unstructured":"A.M. Cali et al. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology 49(6), 1896\u20131903 (2009)","journal-title":"Hepatology"},{"issue":"1","key":"3642_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00394-018-1790-2","volume":"58","author":"S Torres","year":"2019","unstructured":"S. Torres et al. Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics. Eur. J. Nutr. 58(1), 27\u201343 (2019)","journal-title":"Eur. J. Nutr."},{"issue":"6","key":"3642_CR29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1203\/01.pdr.0000262638.48304.ef","volume":"61","author":"A Korner","year":"2007","unstructured":"A. Korner et al. New predictors of the metabolic syndrome in children\u2013role of adipocytokines. Pediatr. Res. 61(6), 640\u2013645 (2007)","journal-title":"Pediatr. Res."},{"key":"3642_CR30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fendo.2019.00514","volume":"10","author":"E D\u2019Adamo","year":"2019","unstructured":"E. D\u2019Adamo, V. Castorani, V. Nobili, The liver in children with metabolic syndrome. Front. Endocrinol. 10, 514 (2019)","journal-title":"Front. Endocrinol."},{"issue":"1","key":"3642_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0038-1627456","volume":"38","author":"JP Mann","year":"2018","unstructured":"J.P. Mann et al. Nonalcoholic fatty liver disease in children. Semin Liver Dis. 38(1), 1\u201313 (2018)","journal-title":"Semin Liver Dis."},{"issue":"1","key":"3642_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/nyas.12030","volume":"1281","author":"R Weiss","year":"2013","unstructured":"R. Weiss, A.A. Bremer, R.H. Lustig, What is metabolic syndrome, and why are children getting it? Ann. N. Y. Acad. Sci. 1281(1), 123\u2013140 (2013)","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Suppl 3","key":"3642_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1046\/j.1365-2362.32.s3.3.x","volume":"32","author":"G Boden","year":"2002","unstructured":"G. Boden, G.I. Shulman, Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur. J. Clin. Invest. 32(Suppl 3), 14\u201323 (2002)","journal-title":"Eur. J. Clin. Invest"},{"key":"3642_CR34","doi-asserted-by":"publisher","first-page":"972975","DOI":"10.3389\/fped.2022.972975","volume":"10","author":"MH Aliusef","year":"2022","unstructured":"M.H. Aliusef et al. Clustering patterns of metabolic syndrome: A cross-sectional study in children and adolescents in Kyiv. Front. Pediatr. 10, 972975 (2022)","journal-title":"Front. Pediatr."},{"issue":"4","key":"3642_CR35","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1161\/CIRCULATIONAHA.108.191394","volume":"119","author":"J Steinberger","year":"2009","unstructured":"J. Steinberger et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 119(4), 628\u2013647 (2009)","journal-title":"Circulation"},{"issue":"5708","key":"3642_CR36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1126\/science.1104345","volume":"307","author":"CJ Rhodes","year":"2005","unstructured":"C.J. Rhodes, Type 2 diabetes-a matter of beta-cell life and death?. Science 307(5708), 380\u2013384 (2005)","journal-title":"Science"},{"issue":"31","key":"3642_CR37","doi-asserted-by":"publisher","first-page":"12587","DOI":"10.1073\/pnas.0705408104","volume":"104","author":"KF Petersen","year":"2007","unstructured":"K.F. Petersen et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc. Natl Acad. Sci. USA 104(31), 12587\u201312594 (2007)","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"3","key":"3642_CR38","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3945\/ajcn.2010.29270","volume":"92","author":"E D\u2019Adamo","year":"2010","unstructured":"E. D\u2019Adamo et al. Ethnic differences in lipoprotein subclasses in obese adolescents: importance of liver and intraabdominal fat accretion. Am. J. Clin. Nutr. 92(3), 500\u2013508 (2010)","journal-title":"Am. J. Clin. Nutr."},{"issue":"6","key":"3642_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1515\/jpem-2016-0404","volume":"30","author":"PC Brar","year":"2017","unstructured":"P.C. Brar, P. Patel, S. Katz, The relationship between insulin resistance and endothelial dysfunction in obese adolescents. J. Pediatr. Endocrinol. Metab. 30(6), 635\u2013642 (2017)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"3642_CR40","first-page":"204","volume":"9","author":"M Simunovic","year":"2022","unstructured":"M. Simunovic et al. The Role of Urotensin-II in obesity and metabolic syndrome in pediatric population. Children (Basel) 9(2), 204 (2022).","journal-title":"Children (Basel)"},{"issue":"5","key":"3642_CR41","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.peptides.2007.06.003","volume":"29","author":"KL Ong","year":"2008","unstructured":"K.L. Ong, L.Y. Wong, B.M. Cheung, The role of urotensin II in the metabolic syndrome. Peptides 29(5), 859\u2013867 (2008)","journal-title":"Peptides"},{"issue":"3","key":"3642_CR42","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1096\/fj.13-236471","volume":"28","author":"Z You","year":"2014","unstructured":"Z. You et al. Blocking the urotensin II receptor pathway ameliorates the metabolic syndrome and improves cardiac function in obese mice. FASEB J. 28(3), 1210\u20131220 (2014)","journal-title":"FASEB J."},{"issue":"7","key":"3642_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.numecd.2008.11.002","volume":"19","author":"A Bellia","year":"2009","unstructured":"A. Bellia et al. The Linosa Study\u201d: epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate. Nutr. Metab. Cardiovasc Dis. 19(7), 455\u2013461 (2009)","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"issue":"5","key":"3642_CR44","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/sj.ijo.0803481","volume":"31","author":"A Bosy-Westphal","year":"2007","unstructured":"A. Bosy-Westphal et al. Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance: the Kiel obesity prevention study. Int J. Obes. 31(5), 784\u2013790 (2007)","journal-title":"Int J. Obes."},{"issue":"9","key":"3642_CR45","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/jmg.2008.058388","volume":"45","author":"P Henneman","year":"2008","unstructured":"P. Henneman et al. Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study. J. Med. Genet. 45(9), 572\u2013577 (2008)","journal-title":"J. Med. Genet."},{"issue":"11","key":"3642_CR46","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/j.1467-789X.2011.00907.x","volume":"12","author":"CM Povel","year":"2011","unstructured":"C.M. Povel et al. Genetic variants and the metabolic syndrome: a systematic review. Obes. Rev. 12(11), 952\u2013967 (2011)","journal-title":"Obes. Rev."},{"issue":"1","key":"3642_CR47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.18632\/aging.101360","volume":"10","author":"M Szkup","year":"2018","unstructured":"M. Szkup et al. Associations between the components of metabolic syndrome and the polymorphisms in the peroxisome proliferator-activated receptor gamma (PPAR-gamma), the fat mass and obesity-associated (FTO), and the melanocortin-4 receptor (MC4R) genes. Aging 10(1), 72\u201382 (2018)","journal-title":"Aging"},{"issue":"5826","key":"3642_CR48","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.1141634","volume":"316","author":"TM Frayling","year":"2007","unstructured":"T.M. Frayling et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316(5826), 889\u2013894 (2007)","journal-title":"Science"},{"issue":"6","key":"3642_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/gm157","volume":"2","author":"H Choquet","year":"2010","unstructured":"H. Choquet, D. Meyre, Genomic insights into early-onset obesity. Genome Med. 2(6), 36 (2010)","journal-title":"Genome Med."},{"issue":"5","key":"3642_CR50","doi-asserted-by":"publisher","first-page":"102234","DOI":"10.1016\/j.dsx.2021.102234","volume":"15","author":"SA Dastgheib","year":"2021","unstructured":"S.A. Dastgheib et al. Evidence from a meta-analysis for association of MC4R rs17782313 and FTO rs9939609 polymorphisms with susceptibility to obesity in children. Diabetes Metab. Syndr. 15(5), 102234 (2021)","journal-title":"Diabetes Metab. Syndr."},{"issue":"5","key":"3642_CR51","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1007\/s11033-011-1377-y","volume":"39","author":"H Wang","year":"2012","unstructured":"H. Wang et al. Genetic variants in FTO associated with metabolic syndrome: a meta- and gene-based analysis. Mol. Biol. Rep. 39(5), 5691\u20135698 (2012)","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"3642_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-017-0443-2","volume":"18","author":"N Sikhayeva","year":"2017","unstructured":"N. Sikhayeva et al. Association between 28 single nucleotide polymorphisms and type 2 diabetes mellitus in the Kazakh population: a case-control study. BMC Med. Genet. 18(1), 76 (2017)","journal-title":"BMC Med. Genet."},{"issue":"5","key":"3642_CR53","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.2337\/db07-1466","volume":"57","author":"RM Freathy","year":"2008","unstructured":"R.M. Freathy et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes 57(5), 1419\u20131426 (2008)","journal-title":"Diabetes"},{"issue":"1","key":"3642_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64031-2","volume":"10","author":"R Nagrani","year":"2020","unstructured":"R. Nagrani et al. Common genetic variation in obesity, lipid transfer genes and risk of Metabolic Syndrome: Results from IDEFICS\/I.Family study and meta-analysis. Sci. Rep. 10(1), 7189 (2020)","journal-title":"Sci. Rep."},{"issue":"2","key":"3642_CR55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.gene.2013.11.006","volume":"535","author":"X Zhao","year":"2014","unstructured":"X. Zhao et al. An obesity genetic risk score is associated with metabolic syndrome in Chinese children. Gene 535(2), 299\u2013302 (2014)","journal-title":"Gene"},{"issue":"11","key":"3642_CR56","first-page":"1079","volume":"18","author":"M Heidari-Beni","year":"2015","unstructured":"M. Heidari-Beni et al. Interaction of cholesterol ester transfer protein polymorphisms, body mass index, and birth weight with the risk of dyslipidemia in children and adolescents: the CASPIAN-III study. Iran. J. Basic Med Sci. 18(11), 1079\u20131085 (2015)","journal-title":"Iran. J. Basic Med Sci."},{"issue":"11","key":"3642_CR57","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1161\/01.ATV.17.11.2753","volume":"17","author":"RA Hegele","year":"1997","unstructured":"R.A. Hegele et al. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins. Arterioscler Thromb. Vasc. Biol. 17(11), 2753\u20132758 (1997)","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"issue":"2","key":"3642_CR58","doi-asserted-by":"publisher","first-page":"e56216","DOI":"10.1371\/journal.pone.0056216","volume":"8","author":"C Xu","year":"2013","unstructured":"C. Xu et al. Effects of APOA5 -1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysis. PLoS One 8(2), e56216 (2013)","journal-title":"PLoS One"},{"issue":"6","key":"3642_CR59","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/lipd.12270","volume":"55","author":"NTH Hanh","year":"2020","unstructured":"N.T.H. Hanh et al. The APOA5-rs662799 polymorphism is a determinant of Dyslipidemia in Vietnamese primary school children. Lipids 55(6), 683\u2013691 (2020)","journal-title":"Lipids"},{"issue":"4","key":"3642_CR60","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0022-2275(20)41611-6","volume":"33","author":"J Dallongeville","year":"1992","unstructured":"J. Dallongeville, S. Lussier-Cacan, J. Davignon, Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J. Lipid Res. 33(4), 447\u2013454 (1992)","journal-title":"J. Lipid Res."},{"issue":"12","key":"3642_CR61","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.metabol.2004.06.017","volume":"53","author":"NT Nghiem","year":"2004","unstructured":"N.T. Nghiem et al. Apolipoprotein E polymorphism in Vietnamese children and its relationship to plasma lipid and lipoprotein levels. Metabolism 53(12), 1517\u20131521 (2004)","journal-title":"Metabolism"},{"issue":"1","key":"3642_CR62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0021-9150(96)05937-0","volume":"127","author":"SR Srinivasan","year":"1996","unstructured":"S.R. Srinivasan et al. Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study. Atherosclerosis 127(1), 73\u201379 (1996)","journal-title":"Atherosclerosis"},{"issue":"13","key":"3642_CR63","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1080\/10408398.2018.1437022","volume":"59","author":"PH Fenwick","year":"2019","unstructured":"P.H. Fenwick et al. Lifestyle genomics and the metabolic syndrome: A review of genetic variants that influence response to diet and exercise interventions. Crit. Rev. Food Sci. Nutr. 59(13), 2028\u20132039 (2019)","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"3","key":"3642_CR64","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ng1732","volume":"38","author":"SF Grant","year":"2006","unstructured":"S.F. Grant et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38(3), 320\u2013323 (2006)","journal-title":"Nat. Genet."},{"issue":"8","key":"3642_CR65","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11886-016-0755-4","volume":"18","author":"AE Brown","year":"2016","unstructured":"A.E. Brown, M. Walker, Genetics of Insulin resistance and the metabolic syndrome. Curr. Cardiol. Rep. 18(8), 75 (2016)","journal-title":"Curr. Cardiol. Rep."},{"issue":"9","key":"3642_CR66","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1210\/jc.2009-0609","volume":"94","author":"PH Liu","year":"2009","unstructured":"P.H. Liu et al. Genetic variants of TCF7L2 are associated with insulin resistance and related metabolic phenotypes in Taiwanese adolescents and Caucasian young adults. J. Clin. Endocrinol. Metab. 94(9), 3575\u20133582 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3642_CR67","first-page":"213","volume":"25","author":"J Yang","year":"2016","unstructured":"J. Yang et al. Melanocortin-4 receptor rs17782313 polymorphisms are associated with serum triglycerides in older Chinese women. Asia Pac. J. Clin. Nutr. 25(1), 213\u2013219 (2016)","journal-title":"Asia Pac. J. Clin. Nutr."},{"issue":"1","key":"3642_CR68","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ymgme.2011.01.007","volume":"103","author":"S Beckers","year":"2011","unstructured":"S. Beckers et al. Association study of MC4R with complex obesity and replication of the rs17782313 association signal. Mol. Genet. Metab. 103(1), 71\u201375 (2011)","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"3642_CR69","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ng.140","volume":"40","author":"RJ Loos","year":"2008","unstructured":"R.J. Loos et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat. Genet. 40(6), 768\u2013775 (2008)","journal-title":"Nat. Genet."},{"issue":"8","key":"3642_CR70","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/s41366-022-01139-7","volume":"46","author":"KJ Roberts","year":"2022","unstructured":"K.J. Roberts et al. Testing for rare genetic causes of obesity: findings and experiences from a pediatric weight management program. Int. J. Obes. 46(8), 1493\u20131501 (2022)","journal-title":"Int. J. Obes."},{"issue":"11","key":"3642_CR71","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1210\/jc.2016-1992","volume":"101","author":"F Lauria","year":"2016","unstructured":"F. Lauria et al. A common variant and the transcript levels of MC4R gene are associated with adiposity in children: The IDEFICS Study. J. Clin. Endocrinol. Metab. 101(11), 4229\u20134236 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3642_CR72","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s12020-018-1587-3","volume":"60","author":"SM Almeida","year":"2018","unstructured":"S.M. Almeida et al. Association between LEPR, FTO, MC4R, and PPARG-2 polymorphisms with obesity traits and metabolic phenotypes in school-aged children. Endocrine 60(3), 466\u2013478 (2018)","journal-title":"Endocrine"},{"issue":"1","key":"3642_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64833-4","volume":"10","author":"A Cortes-Martin","year":"2020","unstructured":"A. Cortes-Martin et al. Genetic polymorphisms, Mediterranean diet and microbiota-associated urolithin metabotypes can predict obesity in childhood-adolescence. Sci. Rep. 10(1), 7850 (2020)","journal-title":"Sci. Rep."},{"issue":"1","key":"3642_CR74","first-page":"40","volume":"31","author":"XCC Aradillas-Garc","year":"2016","unstructured":"X.C.C. Aradillas-Garc et al. Obesity is associated with the Arg389Gly ADRB1 but not with the Trp64Arg ADRB3 polymorphism in children from San Luis PotosI and Leon, Mexico. J. Biomed. Res. 31(1), 40\u201346 (2016)","journal-title":"J. Biomed. Res."},{"issue":"8","key":"3642_CR75","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/sj.ijo.0803281","volume":"30","author":"S Li","year":"2006","unstructured":"S. Li et al. Influence of lipoprotein lipase gene Ser447Stop and beta1-adrenergic receptor gene Arg389Gly polymorphisms and their interaction on obesity from childhood to adulthood: the Bogalusa Heart Study. Int. J. Obes. 30(8), 1183\u20131188 (2006)","journal-title":"Int. J. Obes."},{"issue":"10","key":"3642_CR76","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.2337\/diabetes.54.10.3043","volume":"54","author":"A Meirhaeghe","year":"2005","unstructured":"A. Meirhaeghe et al. Association between peroxisome proliferator-activated receptor gamma haplotypes and the metabolic syndrome in French men and women. Diabetes 54(10), 3043\u20133048 (2005)","journal-title":"Diabetes"},{"issue":"6","key":"3642_CR77","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1203\/01.pdr.0000185272.46705.18","volume":"58","author":"NF Butte","year":"2005","unstructured":"N.F. Butte et al. Quantitative genetic analysis of the metabolic syndrome in Hispanic children. Pediatr. Res. 58(6), 1243\u20131248 (2005)","journal-title":"Pediatr. Res."},{"issue":"4","key":"3642_CR78","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ymgme.2014.04.007","volume":"112","author":"AT Kraja","year":"2014","unstructured":"A.T. Kraja et al. Pleiotropic genes for metabolic syndrome and inflammation. Mol. Genet. Metab. 112(4), 317\u2013338 (2014)","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"3642_CR79","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1017\/S2040174410000115","volume":"1","author":"PM Catalano","year":"2010","unstructured":"P.M. Catalano, The impact of gestational diabetes and maternal obesity on the mother and her offspring. J. Dev. Orig. Health Dis. 1(4), 208\u2013215 (2010)","journal-title":"J. Dev. Orig. Health Dis."},{"issue":"1","key":"3642_CR80","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11892-010-0156-9","volume":"11","author":"SJ Herring","year":"2011","unstructured":"S.J. Herring, E. Oken, Obesity and diabetes in mothers and their children: can we stop the intergenerational cycle? Curr. Diab. Rep. 11(1), 20\u201327 (2011)","journal-title":"Curr. Diab. Rep."},{"issue":"7","key":"3642_CR81","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"K.G. Alberti, P.Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15(7), 539\u2013553 (1998)","journal-title":"Diabet. Med."},{"issue":"5","key":"3642_CR82","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","volume":"16","author":"B Balkau","year":"1999","unstructured":"B. Balkau, M.A. Charles, Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet. Med. 16(5), 442\u2013443 (1999)","journal-title":"Diabet. Med."},{"issue":"1","key":"3642_CR83","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1055\/s-0043-106439","volume":"126","author":"S Taghizadeh","year":"2018","unstructured":"S. Taghizadeh, M. Alizadeh, The role of lipids in the pathogenesis of metabolic syndrome in adolescents. Exp. Clin. Endocrinol. Diabetes 126(1), 14\u201322 (2018)","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"1","key":"3642_CR84","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2337\/diabetes.51.1.204","volume":"51","author":"SR Srinivasan","year":"2002","unstructured":"S.R. Srinivasan, L. Myers, G.S. Berenson, Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes 51(1), 204\u2013209 (2002)","journal-title":"Diabetes"},{"issue":"5","key":"3642_CR85","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/ijpo.12083","volume":"11","author":"S Heinzle","year":"2016","unstructured":"S. Heinzle, G.D. Ball, J.L. Kuk, Variations in the prevalence and predictors of prevalent metabolically healthy obesity in adolescents. Pediatr. Obes. 11(5), 425\u2013433 (2016)","journal-title":"Pediatr. Obes."},{"issue":"9","key":"3642_CR86","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.metabol.2014.06.009","volume":"63","author":"S Bluher","year":"2014","unstructured":"S. Bluher, P. Schwarz, Metabolically healthy obesity from childhood to adulthood - Does weight status alone matter? Metabolism 63(9), 1084\u20131092 (2014)","journal-title":"Metabolism"},{"issue":"Suppl 7","key":"3642_CR87","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1093\/aje\/kws236","volume":"176 Suppl 7","author":"S Li","year":"2012","unstructured":"S. Li et al. Relation of childhood obesity\/cardiometabolic phenotypes to adult cardiometabolic profile: the Bogalusa Heart Study. Am. J. Epidemiol. 176 Suppl 7(Suppl 7), S142\u2013S149 (2012)","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"3642_CR88","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/MPG.0000000000003097","volume":"73","author":"AP Nso-Roca","year":"2021","unstructured":"A.P. Nso-Roca et al. Insulin resistance as a diagnostic criterion for metabolically healthy obesity in children. J. Pediatr. Gastroenterol. Nutr. 73(1), 103\u2013109 (2021)","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"12","key":"3642_CR89","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00431-015-2587-4","volume":"174","author":"R Vukovic","year":"2015","unstructured":"R. Vukovic et al. Preserved insulin sensitivity predicts metabolically healthy obese phenotype in children and adolescents. Eur. J. Pediatr. 174(12), 1649\u20131655 (2015)","journal-title":"Eur. J. Pediatr."},{"issue":"23","key":"3642_CR90","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1056\/NEJMoa031049","volume":"350","author":"R Weiss","year":"2004","unstructured":"R. Weiss et al. Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med. 350(23), 2362\u20132374 (2004)","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"3642_CR91","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1542\/pir.2014-0095","volume":"37","author":"C Wittcopp","year":"2016","unstructured":"C. Wittcopp, R. Conroy, Metabolic Syndrome in children and adolescents. Pediatr. Rev. 37(5), 193\u2013202 (2016)","journal-title":"Pediatr. Rev."},{"issue":"3","key":"3642_CR92","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5223\/pghn.2020.23.3.189","volume":"23","author":"HH Wang","year":"2020","unstructured":"H.H. Wang et al. Novel insights into the pathogenesis and management of the metabolic syndrome. Pediatr. Gastroenterol. Hepatol. Nutr. 23(3), 189\u2013230 (2020)","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"issue":"3","key":"3642_CR93","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/0895-7061(95)00345-2","volume":"9","author":"L Taittonen","year":"1996","unstructured":"L. Taittonen et al. Insulin and blood pressure among healthy children. Cardiovascular risk in young Finns. Am. J. Hypertens. 9(3), 194\u2013199 (1996)","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"3642_CR94","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/01.CIR.93.1.54","volume":"93","author":"W Bao","year":"1996","unstructured":"W. Bao, S.R. Srinivasan, G.S. Berenson, Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation 93(1), 54\u201359 (1996)","journal-title":"Circulation"},{"issue":"5","key":"3642_CR95","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","volume":"7","author":"JS Lim","year":"2010","unstructured":"J.S. Lim et al. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol. Hepatol. 7(5), 251\u2013264 (2010)","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"3642_CR96","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrendo.2014.171","volume":"10","author":"CJ Lynch","year":"2014","unstructured":"C.J. Lynch, S.H. Adams, Branched-chain amino acids in metabolic signalling and insulin resistance. Nat. Rev. Endocrinol. 10(12), 723\u2013736 (2014)","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9","key":"3642_CR97","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.2337\/db18-0927","volume":"68","author":"M Zhou","year":"2019","unstructured":"M. Zhou et al. Targeting BCAA catabolism to treat obesity-associated insulin resistance. Diabetes 68(9), 1730\u20131746 (2019)","journal-title":"Diabetes"},{"issue":"8","key":"3642_CR98","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1751-7176.2012.00647.x","volume":"14","author":"AD Sumner","year":"2012","unstructured":"A.D. Sumner, G.L. Sardi, J.F. Reed 3rd, Components of the metabolic syndrome differ between young and old adults in the US population. J. Clin. Hypertens. 14(8), 502\u2013506 (2012)","journal-title":"J. Clin. Hypertens."},{"issue":"4","key":"3642_CR99","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/archpediatrics.2009.3","volume":"163","author":"WD Johnson","year":"2009","unstructured":"W.D. Johnson et al. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. Arch. Pediatr. Adolesc. Med. 163(4), 371\u2013377 (2009)","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"1","key":"3642_CR100","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/1755-5922.12165","volume":"34","author":"M Agirbasli","year":"2016","unstructured":"M. Agirbasli, A.M. Tanrikulu, G.S. Berenson, Metabolic Syndrome: Bridging the gap from childhood to adulthood. Cardiovasc. Ther. 34(1), 30\u201336 (2016)","journal-title":"Cardiovasc. Ther."},{"issue":"8","key":"3642_CR101","doi-asserted-by":"publisher","first-page":"e3457","DOI":"10.1002\/dmrr.3457","volume":"37","author":"N Buchmann","year":"2021","unstructured":"N. Buchmann et al. Vitamin D insufficiency is associated with metabolic syndrome independent of insulin resistance and obesity in young adults - The Berlin Aging Study II. Diabetes Metab. Res. Rev. 37(8), e3457 (2021)","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"5","key":"3642_CR102","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/met.2017.0003","volume":"15","author":"MJ Alkhatatbeh","year":"2017","unstructured":"M.J. Alkhatatbeh et al. High prevalence of Vitamin D deficiency and correlation of serum Vitamin D with cardiovascular risk in patients with metabolic syndrome. Metab. Syndr. Relat. Disord. 15(5), 213\u2013219 (2017)","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"4","key":"3642_CR103","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s11154-020-09575-4","volume":"22","author":"F Tecilazich","year":"2021","unstructured":"F. Tecilazich, A.M. Formenti, A. Giustina, Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects. Rev. Endocr. Metab. Disord. 22(4), 715\u2013727 (2021)","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"3642_CR104","doi-asserted-by":"publisher","first-page":"106793","DOI":"10.1016\/j.phrs.2023.106793","volume":"192","author":"A Corsello","year":"2023","unstructured":"A. Corsello et al. Effects of vitamin D supplementation in obese and overweight children and adolescents: A systematic review and meta-analysis. Pharm. Res. 192, 106793 (2023)","journal-title":"Pharm. Res."},{"issue":"4","key":"3642_CR105","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/oby.23680","volume":"31","author":"EC Jansen","year":"2023","unstructured":"E.C. Jansen et al. Sleep duration and timing are prospectively linked with insulin resistance during late adolescence. Obesity 31(4), 912\u2013922 (2023)","journal-title":"Obesity"},{"issue":"11","key":"3642_CR106","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.5665\/sleep.6234","volume":"39","author":"F Wang","year":"2016","unstructured":"F. Wang et al. Sleep duration and overweight\/obesity in preschool-aged children: a prospective study of up to 48,922 children of the Jiaxing Birth Cohort. Sleep 39(11), 2013\u20132019 (2016)","journal-title":"Sleep"},{"issue":"10","key":"3642_CR107","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1172\/JCI129194","volume":"129","author":"K Dabke","year":"2019","unstructured":"K. Dabke, G. Hendrick, S. Devkota, The gut microbiome and metabolic syndrome. J. Clin. Invest 129(10), 4050\u20134057 (2019)","journal-title":"J. Clin. Invest"},{"issue":"6","key":"3642_CR108","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jsr.12552","volume":"26","author":"S Reutrakul","year":"2017","unstructured":"S. Reutrakul et al. The relationship between sleep and glucagon-like peptide 1 in patients with abnormal glucose tolerance. J. Sleep. Res. 26(6), 756\u2013763 (2017)","journal-title":"J. Sleep. Res."},{"key":"3642_CR109","doi-asserted-by":"publisher","first-page":"105017","DOI":"10.1016\/j.yhbeh.2021.105017","volume":"134","author":"NJ McKay","year":"2021","unstructured":"N.J. McKay et al. Plasma levels of ghrelin and GLP-1, but not leptin or amylin, respond to a psychosocial stressor in women and men. Horm. Behav. 134, 105017 (2021)","journal-title":"Horm. Behav."},{"key":"3642_CR110","doi-asserted-by":"publisher","first-page":"991397","DOI":"10.3389\/fendo.2022.991397","volume":"13","author":"C Liu","year":"2022","unstructured":"C. Liu et al. Circadian secretion rhythm of GLP-1 and its influencing factors. Front. Endocrinol. 13, 991397 (2022)","journal-title":"Front. Endocrinol."},{"issue":"9996","key":"3642_CR111","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","volume":"386","author":"A Lacroix","year":"2015","unstructured":"A. Lacroix et al. Cushing\u2019s syndrome. Lancet 386(9996), 913\u2013927 (2015)","journal-title":"Lancet"},{"issue":"12","key":"3642_CR112","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1210\/jc.2003-030871","volume":"88","author":"G Arnaldi","year":"2003","unstructured":"G. Arnaldi et al. Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88(12), 5593\u20135602 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"3642_CR113","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1055\/s-0042-105280","volume":"124","author":"F Leo","year":"2016","unstructured":"F. Leo et al. Frailty of obese children: evaluation of plasma antioxidant capacity in pediatric obesity. Exp. Clin. Endocrinol. Diabetes 124(8), 481\u2013486 (2016)","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"11","key":"3642_CR114","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s40618-021-01547-y","volume":"44","author":"L Montefusco","year":"2021","unstructured":"L. Montefusco et al. Anti-inflammatory effects of diet and caloric restriction in metabolic syndrome. J. Endocrinol. Invest. 44(11), 2407\u20132415 (2021)","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"3642_CR115","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1758-5996-4-28","volume":"4","author":"D Dallmeier","year":"2012","unstructured":"D. Dallmeier et al. Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study. Diabetol. Metab. Syndr. 4(1), 28 (2012)","journal-title":"Diabetol. Metab. Syndr."},{"issue":"3","key":"3642_CR116","doi-asserted-by":"publisher","first-page":"e0281381","DOI":"10.1371\/journal.pone.0281381","volume":"18","author":"I Cura-Esquivel","year":"2023","unstructured":"I. Cura-Esquivel et al. Metabolic, inflammatory and adipokine differences on overweight\/obese children with and without metabolic syndrome: A cross-sectional study. PLoS One 18(3), e0281381 (2023)","journal-title":"PLoS One"},{"key":"3642_CR117","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.toxrep.2021.08.004","volume":"8","author":"E Vassilopoulou","year":"2021","unstructured":"E. Vassilopoulou et al. Adipokines and C-reactive protein as indicators of MetS presence in obese Greek children: The Healthy Growth Study. Toxicol. Rep. 8, 1645\u20131650 (2021)","journal-title":"Toxicol. Rep."},{"issue":"1","key":"3642_CR118","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pcl.2018.08.004","volume":"66","author":"E Nehus","year":"2019","unstructured":"E. Nehus, M. Mitsnefes, Childhood obesity and the metabolic syndrome. Pediatr. Clin. North Am. 66(1), 31\u201343 (2019)","journal-title":"Pediatr. Clin. North Am."},{"issue":"6","key":"3642_CR119","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.cell.2014.10.058","volume":"159","author":"SE Simonds","year":"2014","unstructured":"S.E. Simonds et al. Leptin mediates the increase in blood pressure associated with obesity. Cell 159(6), 1404\u20131416 (2014)","journal-title":"Cell"},{"issue":"10","key":"3642_CR120","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1210\/jc.2002-020694","volume":"87","author":"N Stefan","year":"2002","unstructured":"N. Stefan et al. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J. Clin. Endocrinol. Metab. 87(10), 4652\u20134656 (2002). p","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"20","key":"3642_CR121","doi-asserted-by":"publisher","first-page":"7575","DOI":"10.3390\/ijerph17207575","volume":"17","author":"G Rowicka","year":"2020","unstructured":"G. Rowicka et al. Serum Calprotectin and Chemerin concentrations as markers of low-grade inflammation in prepubertal children with obesity. Int. J. Environ. Res. Public Health 17(20), 7575 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"3642_CR122","doi-asserted-by":"publisher","first-page":"117955651985378","DOI":"10.1177\/1179556519853780","volume":"13","author":"HJ Ba","year":"2019","unstructured":"H.J. Ba et al. Serum Chemerin levels correlate with determinants of metabolic syndrome in obese children and adolescents. Clin. Med. Insights Pediatr. 13, 1179556519853780 (2019)","journal-title":"Clin. Med. Insights Pediatr."},{"issue":"2","key":"3642_CR123","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/nu13020289","volume":"13","author":"A Marti","year":"2021","unstructured":"A. Marti et al. Higher Lipopolysaccharide binding protein and chemerin concentrations were associated with metabolic syndrome features in pediatric subjects with abdominal obesity during a lifestyle intervention. Nutrients 13(2), 289 (2021)","journal-title":"Nutrients"},{"issue":"4","key":"3642_CR124","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.bbrc.2005.06.202","volume":"334","author":"N Silswal","year":"2005","unstructured":"N. Silswal et al. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem. Biophys. Res Commun. 334(4), 1092\u20131101 (2005)","journal-title":"Biochem. Biophys. Res Commun."},{"issue":"5","key":"3642_CR125","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1210\/jcem.87.5.8627","volume":"87","author":"PG McTernan","year":"2002","unstructured":"P.G. McTernan et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J. Clin. Endocrinol. Metab. 87(5), 2407 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6818","key":"3642_CR126","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35053000","volume":"409","author":"CM Steppan","year":"2001","unstructured":"C.M. Steppan et al. The hormone resistin links obesity to diabetes. Nature 409(6818), 307\u2013312 (2001)","journal-title":"Nature"},{"issue":"1","key":"3642_CR127","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.diabet.2007.09.004","volume":"34","author":"B Antuna-Puente","year":"2008","unstructured":"B. Antuna-Puente et al. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 34(1), 2\u201311 (2008)","journal-title":"Diabetes Metab."},{"issue":"4","key":"3642_CR128","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1210\/jc.2003-031410","volume":"89","author":"LK Heilbronn","year":"2004","unstructured":"L.K. Heilbronn et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J. Clin. Endocrinol. Metab. 89(4), 1844\u20131848 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"3642_CR129","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1210\/jc.2003-030519","volume":"88","author":"JH Lee","year":"2003","unstructured":"J.H. Lee et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab. 88(10), 4848\u20134856 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"3642_CR130","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1210\/jc.2002-021604","volume":"88","author":"M Yannakoulia","year":"2003","unstructured":"M. Yannakoulia et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J. Clin. Endocrinol. Metab. 88(4), 1730\u20131736 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3642_CR131","first-page":"64","volume":"11","author":"M Yuan","year":"2020","unstructured":"M. Yuan, et al. Asprosin: A novel player in metabolic diseases. Endocrinol 11, 64 (2020).","journal-title":"Endocrinol"},{"key":"3642_CR132","doi-asserted-by":"publisher","first-page":"155477","DOI":"10.1016\/j.cyto.2021.155477","volume":"142","author":"D Corica","year":"2021","unstructured":"D. Corica et al. Asprosin serum levels and glucose homeostasis in children with obesity. Cytokine 142, 155477 (2021).","journal-title":"Cytokine"},{"key":"3642_CR133","doi-asserted-by":"publisher","first-page":"805700","DOI":"10.3389\/fendo.2021.805700","volume":"12","author":"D Corica","year":"2021","unstructured":"D. Corica et al. Meal-related Asprosin serum levels are affected by insulin resistance and impaired fasting glucose in children with obesity. Front. Endocrinol. 12, 805700 (2021)","journal-title":"Front. Endocrinol."},{"issue":"5","key":"3642_CR134","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/labmed\/lmac152","volume":"54","author":"N Moradi","year":"2023","unstructured":"N. Moradi et al. Meteorin-like protein and Asprosin levels in children and adolescents with obesity and their relationship with insulin resistance and metabolic syndrome. Lab. Med. 54(5), 457\u2013463 (2023)","journal-title":"Lab. Med."},{"issue":"5","key":"3642_CR135","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"GS Hotamisligil","year":"1995","unstructured":"G.S. Hotamisligil et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95(5), 2409\u20132415 (1995)","journal-title":"J. Clin. Invest."},{"issue":"1","key":"3642_CR136","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1079\/PNS2004405","volume":"64","author":"HM Roche","year":"2005","unstructured":"H.M. Roche, Fatty acids and the metabolic syndrome. Proc. Nutr. Soc. 64(1), 23\u201329 (2005)","journal-title":"Proc. Nutr. Soc."},{"issue":"4","key":"3642_CR137","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2337\/diacare.28.4.878","volume":"28","author":"ES Ford","year":"2005","unstructured":"E.S. Ford et al. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 28(4), 878\u2013881 (2005)","journal-title":"Diabetes Care"},{"issue":"1","key":"3642_CR138","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0021-9150(99)00312-3","volume":"149","author":"DG Cook","year":"2000","unstructured":"D.G. Cook et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 149(1), 139\u2013150 (2000)","journal-title":"Atherosclerosis"},{"issue":"2","key":"3642_CR139","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4161\/21623945.2014.979661","volume":"4","author":"C Bing","year":"2015","unstructured":"C. Bing, Is interleukin-1beta a culprit in macrophage-adipocyte crosstalk in obesity? Adipocyte 4(2), 149\u2013152 (2015)","journal-title":"Adipocyte"},{"issue":"3","key":"3642_CR140","doi-asserted-by":"publisher","first-page":"610","DOI":"10.2337\/db15-1478","volume":"65","author":"R Kursawe","year":"2016","unstructured":"R. Kursawe et al. A role of the inflammasome in the low storage capacity of the abdominal subcutaneous adipose tissue in obese adolescents. Diabetes 65(3), 610\u2013618 (2016)","journal-title":"Diabetes"},{"issue":"2","key":"3642_CR141","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00281-017-0666-5","volume":"40","author":"G Grandl","year":"2018","unstructured":"G. Grandl, C. Wolfrum, Hemostasis, endothelial stress, inflammation, and the metabolic syndrome. Semin. Immunopathol. 40(2), 215\u2013224 (2018)","journal-title":"Semin. Immunopathol."},{"issue":"8","key":"3642_CR142","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00431-010-1157-z","volume":"169","author":"S Araki","year":"2010","unstructured":"S. Araki et al. Increased plasma isoprostane is associated with visceral fat, high molecular weight adiponectin, and metabolic complications in obese children. Eur. J. Pediatr. 169(8), 965\u2013970 (2010)","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"3642_CR143","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.2047-6310.2012.00135.x","volume":"9","author":"J Warolin","year":"2014","unstructured":"J. Warolin et al. The relationship of oxidative stress, adiposity and metabolic risk factors in healthy Black and White American youth. Pediatr. Obes. 9(1), 43\u201352 (2014)","journal-title":"Pediatr. Obes."},{"issue":"5","key":"3642_CR144","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1017\/S0007114516002804","volume":"116","author":"L Correia-Costa","year":"2016","unstructured":"L. Correia-Costa et al. Oxidative stress and nitric oxide are increased in obese children and correlate with cardiometabolic risk and renal function. Br. J. Nutr. 116(5), 805\u2013815 (2016)","journal-title":"Br. J. Nutr."},{"issue":"1","key":"3642_CR145","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1055\/s-0033-1363423","volume":"23","author":"K Prasad","year":"2014","unstructured":"K. Prasad, Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality. Int. J. Angiol. 23(1), 11\u201316 (2014)","journal-title":"Int. J. Angiol."},{"key":"3642_CR146","doi-asserted-by":"publisher","first-page":"657607","DOI":"10.1155\/2014\/657607","volume":"2014","author":"CT He","year":"2014","unstructured":"C.T. He et al. Soluble form of receptor for advanced glycation end products is associated with obesity and metabolic syndrome in adolescents. Int. J. Endocrinol. 2014, 657607 (2014)","journal-title":"Int. J. Endocrinol."},{"key":"3642_CR147","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3389\/fendo.2019.00426","volume":"10","author":"D Corica","year":"2019","unstructured":"D. Corica et al. Could AGE\/RAGE-related oxidative homeostasis dysregulation enhance susceptibility to pathogenesis of cardio-metabolic complications in childhood obesity? Front. Endocrinol. 10, 426 (2019)","journal-title":"Front. Endocrinol."},{"issue":"2","key":"3642_CR148","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.atherosclerosis.2010.12.035","volume":"215","author":"P Codoner-Franch","year":"2011","unstructured":"P. Codoner-Franch et al. Nitric oxide production is increased in severely obese children and related to markers of oxidative stress and inflammation. Atherosclerosis 215(2), 475\u2013480 (2011)","journal-title":"Atherosclerosis"},{"issue":"6","key":"3642_CR149","doi-asserted-by":"publisher","first-page":"e0128140","DOI":"10.1371\/journal.pone.0128140","volume":"10","author":"BJ Krause","year":"2015","unstructured":"B.J. Krause et al. Micro-RNAs Let7e and 126 in plasma as markers of metabolic dysfunction in 10 to 12 years old children. PLoS One 10(6), e0128140 (2015)","journal-title":"PLoS One"},{"issue":"8","key":"3642_CR150","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/s41366-021-00842-1","volume":"45","author":"J Lischka","year":"2021","unstructured":"J. Lischka et al. Circulating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patients. Int. J. Obes. 45(8), 1763\u20131772 (2021)","journal-title":"Int. J. Obes."},{"issue":"5","key":"3642_CR151","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000515720","volume":"14","author":"B Zhang","year":"2021","unstructured":"B. Zhang, L. Xing, B. Wang, Dysregulation of circulating miR-24-3p in children with obesity and its predictive value for metabolic syndrome. Obes. Facts 14(5), 456\u2013462 (2021)","journal-title":"Obes. Facts"},{"issue":"1","key":"3642_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21056-z","volume":"12","author":"NE Hassan","year":"2022","unstructured":"N.E. Hassan et al. Brief overview of dietary intake, some types of gut microbiota, metabolic markers and research opportunities in sample of Egyptian women. Sci. Rep. 12(1), 17291 (2022)","journal-title":"Sci. Rep."},{"issue":"1","key":"3642_CR153","doi-asserted-by":"publisher","first-page":"1960135","DOI":"10.1080\/19490976.2021.1960135","volume":"13","author":"AK Carrizales-Sanchez","year":"2021","unstructured":"A.K. Carrizales-Sanchez et al. Gut microbiota associations with metabolic syndrome and relevance of its study in pediatric subjects. Gut Microbes 13(1), 1960135 (2021)","journal-title":"Gut Microbes"},{"issue":"1","key":"3642_CR154","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12934-020-01319-y","volume":"19","author":"L Gallardo-Becerra","year":"2020","unstructured":"L. Gallardo-Becerra et al. Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children. Micro. Cell Fact. 19(1), 61 (2020)","journal-title":"Micro. Cell Fact."},{"issue":"12","key":"3642_CR155","doi-asserted-by":"publisher","first-page":"1700300","DOI":"10.1002\/mnfr.201700300","volume":"61","author":"C Haro","year":"2017","unstructured":"C. Haro et al. Consumption of two healthy dietary patterns restored microbiota dysbiosis in obese patients with metabolic dysfunction. Mol. Nutr. Food Res. 61(12), 1700300 (2017).","journal-title":"Mol. Nutr. Food Res."},{"key":"3642_CR156","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clnesp.2022.06.009","volume":"50","author":"H Bannazadeh Baghi","year":"2022","unstructured":"H. Bannazadeh Baghi et al. Evaluation of a human gut-associated phage and gut dominant microbial phyla in the metabolic syndrome. Clin. Nutr. ESPEN 50, 133\u2013137 (2022)","journal-title":"Clin. Nutr. ESPEN"},{"issue":"1","key":"3642_CR157","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/1462-2920.13463","volume":"19","author":"A Riva","year":"2017","unstructured":"A. Riva et al. Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations. Environ. Microbiol. 19(1), 95\u2013105 (2017)","journal-title":"Environ. Microbiol."},{"key":"3642_CR158","doi-asserted-by":"publisher","first-page":"636272","DOI":"10.3389\/fendo.2021.636272","volume":"12","author":"X Yuan","year":"2021","unstructured":"X. Yuan et al. Gut microbiota of Chinese obese children and adolescents with and without insulin resistance. Front. Endocrinol. 12, 636272 (2021)","journal-title":"Front. Endocrinol."},{"issue":"1","key":"3642_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/1757-4749-5-10","volume":"5","author":"L Bervoets","year":"2013","unstructured":"L. Bervoets et al. Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut Pathog. 5(1), 10 (2013)","journal-title":"Gut Pathog."},{"key":"3642_CR160","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jnutbio.2015.08.011","volume":"27","author":"C Haro","year":"2016","unstructured":"C. Haro et al. The gut microbial community in metabolic syndrome patients is modified by diet. J. Nutr. Biochem. 27, 27\u201331 (2016)","journal-title":"J. Nutr. Biochem."},{"issue":"11","key":"3642_CR161","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/oby.2012.110","volume":"20","author":"CL Karlsson","year":"2012","unstructured":"C.L. Karlsson et al. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity 20(11), 2257\u20132261 (2012)","journal-title":"Obesity"},{"key":"3642_CR162","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s42003-018-0221-5","volume":"1","author":"S Rampelli","year":"2018","unstructured":"S. Rampelli et al. Pre-obese children\u2019s dysbiotic gut microbiome and unhealthy diets may predict the development of obesity. Commun. Biol. 1, 222 (2018)","journal-title":"Commun. Biol."},{"issue":"3","key":"3642_CR163","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/oby.23081","volume":"29","author":"JR McCann","year":"2021","unstructured":"J.R. McCann et al. The Pediatric Obesity Microbiome and Metabolism Study (POMMS): Methods, baseline data, and early insights. Obesity 29(3), 569\u2013578 (2021). p","journal-title":"Obesity"},{"issue":"1","key":"3642_CR164","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1089\/chi.2015.0194","volume":"13","author":"F Borgo","year":"2017","unstructured":"F. Borgo et al. Relative abundance in bacterial and fungal gut microbes in obese children: a case control study. Child Obes. 13(1), 78\u201384 (2017)","journal-title":"Child Obes."},{"key":"3642_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jnutbio.2019.03.017","volume":"70","author":"JA Santos-Marcos","year":"2019","unstructured":"J.A. Santos-Marcos, F. Perez-Jimenez, A. Camargo, The role of diet and intestinal microbiota in the development of metabolic syndrome. J. Nutr. Biochem. 70, 1\u201327 (2019)","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"3642_CR166","doi-asserted-by":"publisher","first-page":"339","DOI":"10.21307\/pjm-2018-041","volume":"67","author":"R Barczynska","year":"2018","unstructured":"R. Barczynska et al. Bacterial microbiota and fatty acids in the faeces of overweight and obese children. Pol. J. Microbiol. 67(3), 339\u2013345 (2018)","journal-title":"Pol. J. Microbiol."},{"issue":"3","key":"3642_CR167","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12020-018-1605-5","volume":"61","author":"A Pascale","year":"2018","unstructured":"A. Pascale et al. Microbiota and metabolic diseases. Endocrine 61(3), 357\u2013371 (2018)","journal-title":"Endocrine"},{"issue":"4","key":"3642_CR168","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1080\/19490976.2020.1712985","volume":"11","author":"S Moran-Ramos","year":"2020","unstructured":"S. Moran-Ramos et al. Environmental and intrinsic factors shaping gut microbiota composition and diversity and its relation to metabolic health in children and early adolescents: A population-based study. Gut Microbes 11(4), 900\u2013917 (2020)","journal-title":"Gut Microbes"},{"key":"3642_CR169","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3389\/fimmu.2019.01341","volume":"10","author":"A Leshem","year":"2019","unstructured":"A. Leshem, N. Horesh, E. Elinav, Fecal microbial transplantation and its potential application in cardiometabolic syndrome. Front. Immunol. 10, 1341 (2019)","journal-title":"Front. Immunol."},{"issue":"8","key":"3642_CR170","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1210\/jc.2016-1885","volume":"101","author":"T Reinehr","year":"2016","unstructured":"T. Reinehr et al. Which amount of BMI-SDS reduction is necessary to improve cardiovascular risk factors in overweight children? J. Clin. Endocrinol. Metab. 101(8), 3171\u20133179 (2016)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03642-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03642-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03642-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T02:08:22Z","timestamp":1712110102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03642-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":170,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["3642"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03642-x","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,22]]},"assertion":[{"value":"18 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"A.P. is an Associate Editor of Endocrine journal. All other authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}